Skip to main content
Top
Published in: World Journal of Surgery 3/2005

01-03-2005

Molecular Targeting of Pancreatic Disorders

Authors: Kiichi Tamada, M.D, Xiao-Ping Wang, Ph.D., F. Charles Brunicardi, M.D.

Published in: World Journal of Surgery | Issue 3/2005

Login to get access

Abstract

During the last decade significant advances in gene therapy have made it possible to treat various pancreatic disorders in both animal models and in humans. For example, insulin gene delivery to non-β-cell tissues has been shown to reverse hyperglycemia in diabetic mice, and islet transplantation, based on in vitro differentiation of β cells and concomitant gene targeting to prevent host autoimmune responses, has become more feasible. Additionally, introduction of the glucokinase regulatory protein and protein kinase C-ζ have been shown to improve glucose tolerance in non-insulin-dependent diabetes mellitus animal models. Pancreatic cancer studies utilize several DNA-based strategies for tumor treatment including introduction of tumor suppressor genes, suppression of oncogenes, suicide gene/prodrug therapy, and restricted replication-competent virus therapy. Tumor-specific targeting is an important part of suicide gene therapy, and tumor-specific promoters are used for cell-specific targeting. Tumor-specific suicide gene therapy directed by the rat insulin promoter has been used to eliminate insulinoma tumors in a mouse model. This review compiles a compendium of information related to the treatment of pancreatic disorders using gene therapy.
Literature
1.
go back to reference Bell, G, Polonsky, K 2001Diabetes mellitus and genetically programmed defects in beta-cell functionNature414788791CrossRefPubMed Bell, G, Polonsky, K 2001Diabetes mellitus and genetically programmed defects in beta-cell functionNature414788791CrossRefPubMed
2.
go back to reference Harris, M, Robbins, D 1994Prevalence of adult-onset IDDM in the U.Spopulation. Diabetes1713371340 Harris, M, Robbins, D 1994Prevalence of adult-onset IDDM in the U.Spopulation. Diabetes1713371340
3.
go back to reference Graves, P, Barriga, K, Norris, J, et al. 1999Lack of association between early childhood immunizations and beta-cell autoimmunityDiabetes Care2216941697PubMed Graves, P, Barriga, K, Norris, J,  et al. 1999Lack of association between early childhood immunizations and beta-cell autoimmunityDiabetes Care2216941697PubMed
4.
go back to reference Hummel, M, Fuchtenbusch, M, Schenker, M, et al. 2000No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB StudyDiabetes care23969974PubMed Hummel, M, Fuchtenbusch, M, Schenker, M,  et al. 2000No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB StudyDiabetes care23969974PubMed
5.
go back to reference Todd, JA 1999From genome to aetiology in a multifactorial disease, type 1 diabetesBioessay21164174CrossRef Todd, JA 1999From genome to aetiology in a multifactorial disease, type 1 diabetesBioessay21164174CrossRef
6.
7.
go back to reference Buzzetti, R, Quattrocchi, C, Nistico, L 1998Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidenceDiabetes Metab. Rev.14111128CrossRefPubMed Buzzetti, R, Quattrocchi, C, Nistico, L 1998Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidenceDiabetes Metab. Rev.14111128CrossRefPubMed
8.
go back to reference Nistico, L, Buzzetti, R, Pritchard, LE, et al. 1996The CTLA-4 gene region on chromosome 2q33 is linked to and associated with type 1 diabetesHum. Mol. Genet.510751080CrossRefPubMed Nistico, L, Buzzetti, R, Pritchard, LE,  et al. 1996The CTLA-4 gene region on chromosome 2q33 is linked to and associated with type 1 diabetesHum. Mol. Genet.510751080CrossRefPubMed
9.
go back to reference Larsen, Z, Kristiansen, O, Mato, E, et al. 1999IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent)Autoimmunity313542PubMed Larsen, Z, Kristiansen, O, Mato, E,  et al. 1999IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent)Autoimmunity313542PubMed
10.
go back to reference Park, Y, Eisenbarth, GS 2001Genetic susceptibility factors of type 1 diabetes in AsiansDiabetes Metab. Res. Rev.958309311 Park, Y, Eisenbarth, GS 2001Genetic susceptibility factors of type 1 diabetes in AsiansDiabetes Metab. Res. Rev.958309311
11.
go back to reference Ban, Y, Taniyama, M, Tozaki, T, et al. 2001No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese populationAutoimmunity3439431PubMed Ban, Y, Taniyama, M, Tozaki, T,  et al. 2001No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese populationAutoimmunity3439431PubMed
12.
go back to reference Bingley, PJ, Williams, AJ, Gale, EA 1999Optimized autoantibody-based risk assessment in family members: implications for future intervention trialsDiabetes Care2217961801PubMed Bingley, PJ, Williams, AJ, Gale, EA 1999Optimized autoantibody-based risk assessment in family members: implications for future intervention trialsDiabetes Care2217961801PubMed
13.
go back to reference Verge, CF, Stenger, D, Bonifacio, E, et al. 1998Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody WorkshopDiabetes4718571866PubMed Verge, CF, Stenger, D, Bonifacio, E,  et al. 1998Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody WorkshopDiabetes4718571866PubMed
14.
go back to reference Atkinson, M, Eisenbarth, G 2001Type 1 diabetes: new perspective on disease pathogenesis and treatmentLancet358221229CrossRefPubMed Atkinson, M, Eisenbarth, G 2001Type 1 diabetes: new perspective on disease pathogenesis and treatmentLancet358221229CrossRefPubMed
15.
go back to reference Iwagawa, A, Hanafusa, T, Itoh, N, et al. 1999Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset type 1 (insulin-dependent) diabetes mellitusDiabetologia42574579CrossRefPubMed Iwagawa, A, Hanafusa, T, Itoh, N,  et al. 1999Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset type 1 (insulin-dependent) diabetes mellitusDiabetologia42574579CrossRefPubMed
16.
go back to reference Imagawa, A, Hanafusa, T, Tamura, S, et al. 2001Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunityDiabetes5012691273PubMed Imagawa, A, Hanafusa, T, Tamura, S,  et al. 2001Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunityDiabetes5012691273PubMed
17.
go back to reference Martin, S, Engel, N, Vinke, A, et al. 2001Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic miceJ. Autoimmun.17109117CrossRefPubMed Martin, S, Engel, N, Vinke, A,  et al. 2001Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic miceJ. Autoimmun.17109117CrossRefPubMed
18.
go back to reference Katz, SM, Bennett, F, Stecker, K, et al. 2000ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and functionCell Transplant9817828PubMed Katz, SM, Bennett, F, Stecker, K,  et al. 2000ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and functionCell Transplant9817828PubMed
19.
go back to reference Nejentsev, S, Laine, A, Simell, O, et al. 2000Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among FinnsTissue Antig.55568570 Nejentsev, S, Laine, A, Simell, O,  et al. 2000Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among FinnsTissue Antig.55568570
20.
go back to reference Group TDCaCTR.1993The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitusN.Engl. J. Med.72977986 Group TDCaCTR.1993The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitusN.Engl. J. Med.72977986
21.
go back to reference Hanazaki, K, Nose, Y, Brunicardi, R 2001Artificial endocrine pancreasJ. Am. Coll. Surg193310322PubMed Hanazaki, K, Nose, Y, Brunicardi, R 2001Artificial endocrine pancreasJ. Am. Coll. Surg193310322PubMed
22.
go back to reference Shapiro, A, Lakey, J, Ryan, E, et al. 2000Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimenN. Engl. J. Med343230238PubMed Shapiro, A, Lakey, J, Ryan, E,  et al. 2000Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimenN. Engl. J. Med343230238PubMed
23.
go back to reference Boker, A, Rothenberg, L, Hernandez, C, et al. 2001Human islet transplantation: updateWorld J. Surg25481486PubMed Boker, A, Rothenberg, L, Hernandez, C,  et al. 2001Human islet transplantation: updateWorld J. Surg25481486PubMed
24.
go back to reference Yoon, JW, Yoon, CS, Lim, HW, et al. 1999Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cellsScience28411831187PubMed Yoon, JW, Yoon, CS, Lim, HW,  et al. 1999Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cellsScience28411831187PubMed
25.
go back to reference Contreras, J, Bilbao, G, Smyth, C, et al. 2001Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complementSurgery130166174PubMed Contreras, J, Bilbao, G, Smyth, C,  et al. 2001Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complementSurgery130166174PubMed
26.
go back to reference Benhamou, P 2002Immunomodulation with CTLA4-Ig in islet transplantationTransplantation73S40S42PubMed Benhamou, P 2002Immunomodulation with CTLA4-Ig in islet transplantationTransplantation73S40S42PubMed
27.
go back to reference Wogensen, L, Lee, M, Sarvetnick, N 1994Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic miceJ. Exp. Med.17913791384PubMed Wogensen, L, Lee, M, Sarvetnick, N 1994Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic miceJ. Exp. Med.17913791384PubMed
28.
go back to reference Moldovan, S, Brunicardi, F 2001Endocrine pancreas: summary of observations generated by surgical fellowsWorld J. Surg.25468473PubMed Moldovan, S, Brunicardi, F 2001Endocrine pancreas: summary of observations generated by surgical fellowsWorld J. Surg.25468473PubMed
29.
go back to reference Duvivier-Kali, V, Omer, A, Parent, R, et al. 2001Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membraneDiabetes5016981705PubMed Duvivier-Kali, V, Omer, A, Parent, R,  et al. 2001Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membraneDiabetes5016981705PubMed
30.
go back to reference Piccirillo, C, Chang, Y, Prud’homme, G 1998TGF-betal somatic gene therapy prevents autoimmune disease in nonobese diabetic miceJ.Immunol.16139503956PubMed Piccirillo, C, Chang, Y, Prud’homme, G 1998TGF-betal somatic gene therapy prevents autoimmune disease in nonobese diabetic miceJ.Immunol.16139503956PubMed
31.
go back to reference Goudy, K, Song, S, Wasserfall, C, et al. 2001Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD miceProc. Natl. Acad. Sci. U.S.A.981391313918PubMed Goudy, K, Song, S, Wasserfall, C,  et al. 2001Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD miceProc. Natl. Acad. Sci. U.S.A.981391313918PubMed
32.
go back to reference Ferber, S, Halkin, A, Cohen, H, et al. 2000Pancreatic and duedenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemiaNat. Med.6568572PubMed Ferber, S, Halkin, A, Cohen, H,  et al. 2000Pancreatic and duedenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemiaNat. Med.6568572PubMed
33.
go back to reference Shifrin, A, Auricchio, A, Yu, Q, et al. 2001Adenovirul vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemiaGene Ther.814801489PubMed Shifrin, A, Auricchio, A, Yu, Q,  et al. 2001Adenovirul vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemiaGene Ther.814801489PubMed
34.
go back to reference Bailey, C, Davies, E, Docherty, K 1999Prospects for insulin delivery by ex-vivo somatic cell gene therapyJ. Mol. Med.77244249PubMed Bailey, C, Davies, E, Docherty, K 1999Prospects for insulin delivery by ex-vivo somatic cell gene therapyJ. Mol. Med.77244249PubMed
35.
go back to reference Lee, H, Kim, S, Kim, K, et al. 2000Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogueNature408483488PubMed Lee, H, Kim, S, Kim, K,  et al. 2000Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogueNature408483488PubMed
36.
go back to reference Rajas, F, Croset, M, Zitoun, C, et al. 2000Induction of PEPCK gene expression in insulinopenia in rat small intestineDiabetes4911651168PubMed Rajas, F, Croset, M, Zitoun, C,  et al. 2000Induction of PEPCK gene expression in insulinopenia in rat small intestineDiabetes4911651168PubMed
37.
go back to reference Soria, B, Roche, E, Berna, G, et al. 2000Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic miceDiabetes49157162PubMed Soria, B, Roche, E, Berna, G,  et al. 2000Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic miceDiabetes49157162PubMed
38.
go back to reference Milo-Landesman, D, Surana, M, Berkovich, , et al. 2001Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory systemCell Transplant.10645650PubMed Milo-Landesman, D, Surana, M, Berkovich, ,  et al. 2001Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory systemCell Transplant.10645650PubMed
39.
go back to reference Tamemoto, H, Kadowaki, T, Tobe, K, et al. 1994Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1Nature372182186PubMed Tamemoto, H, Kadowaki, T, Tobe, K,  et al. 1994Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1Nature372182186PubMed
40.
go back to reference Hart, L, Nijpels, G, Dekker, J, et al. 2002Variations in insulin secretion in carriers of gene variants in IRS-1 and -2Diabetes51884887PubMed Hart, L, Nijpels, G, Dekker, J,  et al. 2002Variations in insulin secretion in carriers of gene variants in IRS-1 and -2Diabetes51884887PubMed
41.
go back to reference Altshuler, D, Hirschhorn, J, Klannemark, M, et al. 2000common PPARgamma Pro 12Ala polymorphism is associated with decreased risk of type 2 diabetesNat. Genet.267680PubMed Altshuler, D, Hirschhorn, J, Klannemark, M,  et al. 2000common PPARgamma Pro 12Ala polymorphism is associated with decreased risk of type 2 diabetesNat. Genet.267680PubMed
42.
go back to reference Stumvoll, M, Stefan, N, Fritsche, A, et al. 2002Interaction effect between common polymorphisms in PPARgamma (2) (Prol2Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivityJ. Mol. Med803338PubMed Stumvoll, M, Stefan, N, Fritsche, A,  et al. 2002Interaction effect between common polymorphisms in PPARgamma (2) (Prol2Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivityJ. Mol. Med803338PubMed
43.
go back to reference Horikawa, Y, Oda, N, Cox, N, et al. 2000Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusNat. Genet.26163175PubMed Horikawa, Y, Oda, N, Cox, N,  et al. 2000Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusNat. Genet.26163175PubMed
44.
go back to reference Elbein, S, Chu, W, Ren, Q, et al. 2002Role of calpain-10 gene variants in familial type 2 diabetes in CaucasiansJ. Clin. Endocrinol. Metab.87650654PubMed Elbein, S, Chu, W, Ren, Q,  et al. 2002Role of calpain-10 gene variants in familial type 2 diabetes in CaucasiansJ. Clin. Endocrinol. Metab.87650654PubMed
45.
go back to reference Schwanstecher, C, Meyer, U, Schwanstecher, M 2002K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channelsDiabetes51875879PubMed Schwanstecher, C, Meyer, U, Schwanstecher, M 2002K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channelsDiabetes51875879PubMed
46.
go back to reference Stumvoll, M, Haring, H 2001Insulin resistance and insulin sensitizersHorm. Res.55313PubMed Stumvoll, M, Haring, H 2001Insulin resistance and insulin sensitizersHorm. Res.55313PubMed
47.
go back to reference Yamamoto, K, Miyagawa, J, Waguri, M, et al. 2000Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusionDiabetes4920212027PubMed Yamamoto, K, Miyagawa, J, Waguri, M,  et al. 2000Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusionDiabetes4920212027PubMed
48.
go back to reference Akiyama, T, Takasawa, S, Nata, K, et al. 2001Activation of Reg gene, a gene for insulin-producing beta-cell regeneration: poly (ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly (ADP-ribosyl)ationProc. Natl. Acad. Sci. U.S.A.984853PubMed Akiyama, T, Takasawa, S, Nata, K,  et al. 2001Activation of Reg gene, a gene for insulin-producing beta-cell regeneration: poly (ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly (ADP-ribosyl)ationProc. Natl. Acad. Sci. U.S.A.984853PubMed
49.
go back to reference Tourrel, C, Bailbe, D, Meile, M, et al. 2001Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult ageDiabetes5015621570PubMed Tourrel, C, Bailbe, D, Meile, M,  et al. 2001Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult ageDiabetes5015621570PubMed
50.
go back to reference Slosberg, ED, Desai, UJ, Fanalli, B, et al. 2001Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory proteinDiabetes5018131820PubMed Slosberg, ED, Desai, UJ, Fanalli, B,  et al. 2001Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory proteinDiabetes5018131820PubMed
51.
go back to reference Kotani, K, Ogawa, W, Matsumoto, M, et al. 1998Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytesMol. Cell. Biol.1869716982PubMed Kotani, K, Ogawa, W, Matsumoto, M,  et al. 1998Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytesMol. Cell. Biol.1869716982PubMed
52.
go back to reference Etgen, G, Valasek, K, Broderick, C, et al. 1999In vivo adenoviral delivery of recombinant human protein kinase C-zeta stimulates glucose transport activity in rat skeletal muscleJ.Biol. Chem.274 2213922142PubMed Etgen, G, Valasek, K, Broderick, C,  et al. 1999In vivo adenoviral delivery of recombinant human protein kinase C-zeta stimulates glucose transport activity in rat skeletal muscleJ.Biol. Chem.274 2213922142PubMed
53.
go back to reference Fajans, S, Bell, G, Polonsky, K 2001Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the youngN. Engl. Med.345971980 Fajans, S, Bell, G, Polonsky, K 2001Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the youngN. Engl. Med.345971980
54.
go back to reference Stoffers, D, Ferrer, J, Clarke, W, et al. 1997Early-onset type-II diabetes mellitus (MODY4) linked to IPF1Na. Genet17138139 Stoffers, D, Ferrer, J, Clarke, W,  et al. 1997Early-onset type-II diabetes mellitus (MODY4) linked to IPF1Na. Genet17138139
55.
go back to reference Leibowitz, G, Ferber, S, Apelqvist, A, et al. 2001IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal with type 2 diabetesDiabetes5017991806PubMed Leibowitz, G, Ferber, S, Apelqvist, A,  et al. 2001IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal with type 2 diabetesDiabetes5017991806PubMed
56.
go back to reference Shimomura, H, Sanke, T, Hanabusa, T, et al. 2000Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family historyDiabetes4915971600PubMed Shimomura, H, Sanke, T, Hanabusa, T,  et al. 2000Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family historyDiabetes4915971600PubMed
57.
go back to reference Miyata, T, Maeda, T, Lee, J 1999NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampusGenes Dev.1316471652PubMed Miyata, T, Maeda, T, Lee, J 1999NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampusGenes Dev.1316471652PubMed
58.
go back to reference Gannon, M, Gamer, L, Wright, C 2001Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdxlDev.Biol.238185201PubMed Gannon, M, Gamer, L, Wright, C 2001Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdxlDev.Biol.238185201PubMed
59.
go back to reference Mergener, K, Baille, J 1997Chronic pancreatitisLancet3503791385PubMed Mergener, K, Baille, J 1997Chronic pancreatitisLancet3503791385PubMed
60.
go back to reference Horiuchi, A, Kawa, S, Hamano, H, et al. 2002ERCP features in 27 patients with autoimmune pancreatitisGastrointest. Endosc.55494499PubMed Horiuchi, A, Kawa, S, Hamano, H,  et al. 2002ERCP features in 27 patients with autoimmune pancreatitisGastrointest. Endosc.55494499PubMed
61.
go back to reference Lowenfels, A, Maisonneuve, P, Cavallini, G, et al. 1994Prognosis of chronic pancreatitis: an international multicenter studyAm. J. Gastroenterol.8914671471PubMed Lowenfels, A, Maisonneuve, P, Cavallini, G,  et al. 1994Prognosis of chronic pancreatitis: an international multicenter studyAm. J. Gastroenterol.8914671471PubMed
62.
go back to reference Bansal, P, Sonnenberg, A 1995Pancreatitis is a risk factor for pancreatic cancerGastroenterology109247251PubMed Bansal, P, Sonnenberg, A 1995Pancreatitis is a risk factor for pancreatic cancerGastroenterology109247251PubMed
63.
go back to reference O’Reilly, DA, Yang, B, Creightonc, JE, et al. 2001Mutations of the cationic trypsinogen gene in hereditary and non-hereditary-pancreatitisDigestion645460PubMed O’Reilly, DA, Yang, B, Creightonc, JE,  et al. 2001Mutations of the cationic trypsinogen gene in hereditary and non-hereditary-pancreatitisDigestion645460PubMed
64.
go back to reference Whitcomb, D, Applebaum, S, Martin, S 1999Hereditary pancreatitis and pancreatic carcinomaAnn. N.Y. Acad. Sci.880201209PubMed Whitcomb, D, Applebaum, S, Martin, S 1999Hereditary pancreatitis and pancreatic carcinomaAnn. N.Y. Acad. Sci.880201209PubMed
65.
go back to reference Haber, P, Wilson, J, Apte, M, et al. 1995Individual susceptibility to alcoholic pancreatitis: still an enigmaJ. Lab. Clin. Med125305312PubMed Haber, P, Wilson, J, Apte, M,  et al. 1995Individual susceptibility to alcoholic pancreatitis: still an enigmaJ. Lab. Clin. Med125305312PubMed
66.
go back to reference Sharer, N, Schwarz, M, Malone, G, et al. 1998Mutations of the cystic fibrosis gene in patients with chronic pancreatitisN. Engl. J. Med.339645652PubMed Sharer, N, Schwarz, M, Malone, G,  et al. 1998Mutations of the cystic fibrosis gene in patients with chronic pancreatitisN. Engl. J. Med.339645652PubMed
67.
go back to reference Hunger, R, Mueller, C, Z’Graggen, K, et al. 1997Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitisGastroenterology11216561663PubMed Hunger, R, Mueller, C, Z’Graggen, K,  et al. 1997Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitisGastroenterology11216561663PubMed
68.
go back to reference Adamek, H, Jakobs, R, Buttmann, A, et al. 1999Long term follow up of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shock wave lithotripsyGut45402405PubMed Adamek, H, Jakobs, R, Buttmann, A,  et al. 1999Long term follow up of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shock wave lithotripsyGut45402405PubMed
69.
go back to reference Wong, G, Sakorafas, G, et al. 1999Palliation of pain in chronic pancreatitis: use of neural blocks and neurotomySurg. Clin. North. Am.79873893PubMed Wong, G, Sakorafas, G,  et al. 1999Palliation of pain in chronic pancreatitis: use of neural blocks and neurotomySurg. Clin. North. Am.79873893PubMed
70.
go back to reference Mullan, M, Gauger, P, Thompson, N 2001Endocrine tumours of the pancreas: review and recent advancesA.N.Z. J. Surg.71475482 Mullan, M, Gauger, P, Thompson, N 2001Endocrine tumours of the pancreas: review and recent advancesA.N.Z. J. Surg.71475482
71.
go back to reference Lo, C, Lam, K, Kung, A, et al. 1997Pancreatic insulinomas: a 15-year experienceArch. Surg132926930PubMed Lo, C, Lam, K, Kung, A,  et al. 1997Pancreatic insulinomas: a 15-year experienceArch. Surg132926930PubMed
72.
go back to reference Jensen, R 1999Pancreatic endocrine tumors: recent advancesAnn. Oncol.10S170S176 Jensen, R 1999Pancreatic endocrine tumors: recent advancesAnn. Oncol.10S170S176
73.
go back to reference Maton, P, Gardner, J, Jensen, R 1989Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumorsDig. Dis. Sci.34S28S39 Maton, P, Gardner, J, Jensen, R 1989Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumorsDig. Dis. Sci.34S28S39
74.
go back to reference Lissoni, P, Barni, S, Tancini, G, et al. 1995Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumorsOncology52163166PubMed Lissoni, P, Barni, S, Tancini, G,  et al. 1995Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumorsOncology52163166PubMed
75.
go back to reference Schott, M, Feldkamp, J, Lettmann, M, et al. 2001Dendritic cell immunotherapy in a neuroendocrine pancreas carcinomaClin. Endocrinol. (Oxf).55271277 Schott, M, Feldkamp, J, Lettmann, M,  et al. 2001Dendritic cell immunotherapy in a neuroendocrine pancreas carcinomaClin. Endocrinol. (Oxf).55271277
76.
go back to reference Pelengaris, S, Khan, M 2001Oncogenic co-operation in beta-cell tumorigenesisEndocr. Relat. Cancer8307314PubMed Pelengaris, S, Khan, M 2001Oncogenic co-operation in beta-cell tumorigenesisEndocr. Relat. Cancer8307314PubMed
77.
go back to reference Pavelic, K, Hrascan, R, Kapitanovic, S, et al. 1996Molecular genetics of malignant insulinomaAnticancer Res.1617071717PubMed Pavelic, K, Hrascan, R, Kapitanovic, S,  et al. 1996Molecular genetics of malignant insulinomaAnticancer Res.1617071717PubMed
78.
go back to reference Tirone, TA, Pagan, SP, Templeton, NS, et al. 2001Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapyAnn. Surg.233603611CrossRefPubMed Tirone, TA, Pagan, SP, Templeton, NS,  et al. 2001Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapyAnn. Surg.233603611CrossRefPubMed
79.
go back to reference Gold, EB, Goldin, SB 1998Epidemiology of and risk factors for pancreatic cancerSurg. Oncol. Clin. North Am.76791 Gold, EB, Goldin, SB 1998Epidemiology of and risk factors for pancreatic cancerSurg. Oncol. Clin. North Am.76791
80.
go back to reference McMahon, P, Halpera, E, Fernandez-del Castillo, C, et al. 2001Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectabilityRadiology22193106PubMed McMahon, P, Halpera, E, Fernandez-del Castillo, C,  et al. 2001Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectabilityRadiology22193106PubMed
81.
go back to reference Ishikawa, O, Ohigashi, H, Imaoka, S, et al. 1998Minute carcinoma of the pancreas measuring 1 cm or less in diameter—collective review of Japanese case reportsHepatogastroenterology46815 Ishikawa, O, Ohigashi, H, Imaoka, S,  et al. 1998Minute carcinoma of the pancreas measuring 1 cm or less in diameter—collective review of Japanese case reportsHepatogastroenterology46815
82.
go back to reference Ordonez, NG, Mackay, B 2000Acinar cell carcinoma of the pancreasUltrastuct. Pathol.24227241 Ordonez, NG, Mackay, B 2000Acinar cell carcinoma of the pancreasUltrastuct. Pathol.24227241
83.
go back to reference Pourr, PM, Schmied, B 1999The link between exocrine pancreatic cancer and the endocrine pancreasInt. J. Pancreatol.257787PubMed Pourr, PM, Schmied, B 1999The link between exocrine pancreatic cancer and the endocrine pancreasInt. J. Pancreatol.257787PubMed
84.
go back to reference Matsuzaki, H, Schmied, BM, Ulrich, A, et al. 2000In vitro induction of giant cell tumors from cultured hamster islets treated with N-nitrosobis (2-oxopropyl) amineAm. J. Pathol.156439443PubMed Matsuzaki, H, Schmied, BM, Ulrich, A,  et al. 2000In vitro induction of giant cell tumors from cultured hamster islets treated with N-nitrosobis (2-oxopropyl) amineAm. J. Pathol.156439443PubMed
85.
go back to reference Gouma, D, Geenen, R, Gulik, T, et al. 2000Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volumeAnn. Surg.232786795PubMed Gouma, D, Geenen, R, Gulik, T,  et al. 2000Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volumeAnn. Surg.232786795PubMed
86.
go back to reference Ahmad, N, Lewis, J, Ginsberg, G, et al. 2001Long term survival after pancreatic resection for pancreatic adenocarcinomaAm. J. Gastroenterol.9626092615PubMed Ahmad, N, Lewis, J, Ginsberg, G,  et al. 2001Long term survival after pancreatic resection for pancreatic adenocarcinomaAm. J. Gastroenterol.9626092615PubMed
87.
go back to reference Tamada, K, Tomiyama, T, Ohashi, A, et al. 2001Intraductal ultrasonography for evaluating the patency of biliary metallic stents:correlation with cholangioscopic findingsAbdom Imaging26210214PubMed Tamada, K, Tomiyama, T, Ohashi, A,  et al. 2001Intraductal ultrasonography for evaluating the patency of biliary metallic stents:correlation with cholangioscopic findingsAbdom Imaging26210214PubMed
88.
go back to reference Burris, HR, Moore, M, Andersen, J, et al. 1997Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialJ Clin Oncol1524032413PubMed Burris, HR, Moore, M, Andersen, J,  et al. 1997Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialJ Clin Oncol1524032413PubMed
89.
go back to reference McGinn, C, Zalupski, M, Shureiqi, I, et al. 2001Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancerJ. Clin. Oncol.1942024208PubMed McGinn, C, Zalupski, M, Shureiqi, I,  et al. 2001Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancerJ. Clin. Oncol.1942024208PubMed
90.
go back to reference Ghaneh, P, Greenhalf, W, Humphreys, M, et al. 2001Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivoGene Ther8199208CrossRefPubMed Ghaneh, P, Greenhalf, W, Humphreys, M,  et al. 2001Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivoGene Ther8199208CrossRefPubMed
91.
go back to reference Dumon, , Dumon, .K, Ishii H, Vecchione A, et alFragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res2001;6148274836 Dumon, , Dumon,  .K, Ishii H, Vecchione A, et alFragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res2001;6148274836
92.
go back to reference Rigg, A, Lemoine, N 2001Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivoCancer Gene Ther.8869878CrossRefPubMed Rigg, A, Lemoine, N 2001Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivoCancer Gene Ther.8869878CrossRefPubMed
93.
go back to reference Benali, N, Cordelier, P, Calise, D, et al. 2000Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtypes 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238Proc. Natl. Acad. Sci. U.S.A.9791809185CrossRefPubMed Benali, N, Cordelier, P, Calise, D,  et al. 2000Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtypes 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238Proc. Natl. Acad. Sci. U.S.A.9791809185CrossRefPubMed
94.
go back to reference Takeuchi, M, Shichinohe, T, Senmaru, N, et al. 2000The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude miceGene Ther7518–526CrossRefPubMed Takeuchi, M, Shichinohe, T, Senmaru, N,  et al. 2000The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude miceGene Ther7518–526CrossRefPubMed
95.
go back to reference Su, Z, Lebedeva, I, Gopalkrishnan, R, et al. 2001combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cellsProc. Natl. Acad. Sci. U.S.A..1033210337PubMed Su, Z, Lebedeva, I, Gopalkrishnan, R,  et al. 2001combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cellsProc. Natl. Acad. Sci. U.S.A..1033210337PubMed
96.
go back to reference Kelley, J, Brown, J, Frasier, M, et al. 2000The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancerSurgery128353360CrossRefPubMed Kelley, J, Brown, J, Frasier, M,  et al. 2000The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancerSurgery128353360CrossRefPubMed
97.
go back to reference Thybusch-Bernhardt, A, Aigner, A, Beckmann, S, et al. 2001Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivoEur. J. Cancer3716881694CrossRefPubMed Thybusch-Bernhardt, A, Aigner, A, Beckmann, S,  et al. 2001Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivoEur. J. Cancer3716881694CrossRefPubMed
98.
go back to reference Kanyama, H, Tomita, N, Yamono, T, et al. 2001Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene thearpyCancer Res.611418PubMed Kanyama, H, Tomita, N, Yamono, T,  et al. 2001Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene thearpyCancer Res.611418PubMed
99.
go back to reference Evoy, D, Hirschowitz, EA, Naama, HA, et al. 1997In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancerJ. Surg. Res.69226231PubMed Evoy, D, Hirschowitz, EA, Naama, HA,  et al. 1997In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancerJ. Surg. Res.69226231PubMed
100.
go back to reference Wang, XP, Yazawa, K, Yang, J, et al. 2004Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase Gene directed by the rat insulin promoterJ. Gastrointest. Surg.898108PubMed Wang, XP, Yazawa, K, Yang, J,  et al. 2004Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase Gene directed by the rat insulin promoterJ. Gastrointest. Surg.898108PubMed
101.
go back to reference Lohr, M, Hoffmeyer, A, Kroger, J, et al. 2001Microencapsulated cell-mediated treatment of inoperable pancreatic carcinomaLancet35715911592PubMed Lohr, M, Hoffmeyer, A, Kroger, J,  et al. 2001Microencapsulated cell-mediated treatment of inoperable pancreatic carcinomaLancet35715911592PubMed
102.
go back to reference Block, A, Chen, SH, Kosai, K, et al. 1997Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumorsPancreas152534PubMed Block, A, Chen, SH, Kosai, K,  et al. 1997Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumorsPancreas152534PubMed
103.
go back to reference Wesseling, J, Yamamoto, M, Adachi, Y, et al. 2001Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinomaCancer Gene Ther.8990996PubMed Wesseling, J, Yamamoto, M, Adachi, Y,  et al. 2001Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinomaCancer Gene Ther.8990996PubMed
104.
go back to reference Carrio, M, Romagosa, A, Mercade, E, et al. 1996Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase geneGene Ther.6547553 Carrio, M, Romagosa, A, Mercade, E,  et al. 1996Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase geneGene Ther.6547553
105.
go back to reference Aoki, K, Yoshida, T, Matsumoto, N, et al. 1997Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase geneHum. Gene Ther.811051113PubMed Aoki, K, Yoshida, T, Matsumoto, N,  et al. 1997Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase geneHum. Gene Ther.811051113PubMed
106.
go back to reference Sander, M, German, M 1997The beta cell transcription factors and development of the pancreasJ. Mol. Med.75327340CrossRefPubMed Sander, M, German, M 1997The beta cell transcription factors and development of the pancreasJ. Mol. Med.75327340CrossRefPubMed
107.
go back to reference Ahlgren, U, Jonsson, J, Edlund, H 1996The morphogenesis of the pancreatic mesenchym is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient miceDevelopment12214091406PubMed Ahlgren, U, Jonsson, J, Edlund, H 1996The morphogenesis of the pancreatic mesenchym is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient miceDevelopment12214091406PubMed
108.
go back to reference Wang, H, Maechler, P, Ritz-Laser, B, et al. 2001Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiationJ. Biol. Chem.2762527925286PubMed Wang, H, Maechler, P, Ritz-Laser, B,  et al. 2001Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiationJ. Biol. Chem.2762527925286PubMed
109.
go back to reference Frazier, M 1999Gene expression in pancreatic adenocarcinomaAnn. N.Y. Acad. Sci.88014 Frazier, M 1999Gene expression in pancreatic adenocarcinomaAnn. N.Y. Acad. Sci.88014
110.
go back to reference Nemunaitis, J, Khuri, F, Ganly, I, et al. 2001Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ. Clin. Oncol.19289298PubMed Nemunaitis, J, Khuri, F, Ganly, I,  et al. 2001Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ. Clin. Oncol.19289298PubMed
111.
go back to reference Mulvihill, S, Warren, R, Venook, A, et al. 2001Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trialGene Ther.8308315PubMed Mulvihill, S, Warren, R, Venook, A,  et al. 2001Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trialGene Ther.8308315PubMed
112.
go back to reference Motoi, F, Sunamura, M, Ding, L, et al. 2000Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirusHum. Gene. Ther.11223235PubMed Motoi, F, Sunamura, M, Ding, L,  et al. 2000Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirusHum. Gene. Ther.11223235PubMed
113.
go back to reference Ahlgren, U, Pfaff, S, Jessel, T, et al. (1997) “Independent requirement for ISL1 in formation of pancreatic messenchyme and islet cells “ Nature 385(6613): 257–260 Ahlgren, U, Pfaff, S, Jessel, T, et al. (1997) “Independent requirement for ISL1 in formation of pancreatic messenchyme and islet cells “ Nature 385(6613): 257–260
114.
go back to reference Sosa-Pineda, B., Chowdhury, K, Torres, M, et al. (1997) “The Pax4 gene is essential for differentiation of insulin-producing cells in the mammalian pancreas” Nature 386: 399–402 Sosa-Pineda, B., Chowdhury, K, Torres, M, et al. (1997) “The Pax4 gene is essential for differentiation of insulin-producing cells in the mammalian pancreas” Nature 386: 399–402
115.
go back to reference St-Onge, L, Sosa-Pineda, B, Chowdhury, K, et al. (1997) “Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas” Nature 387(6631): 406–409 St-Onge, L, Sosa-Pineda, B, Chowdhury, K, et al. (1997) “Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas” Nature 387(6631): 406–409
116.
go back to reference Gradwohl, GDA, LeMeur, M, Gullemot, F (2000) “Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas” Proc Natl Acad Sci USa 97: 1607–1611 Gradwohl, GDA, LeMeur, M, Gullemot, F (2000) “Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas” Proc Natl Acad Sci USa 97: 1607–1611
117.
go back to reference Sussel, I, Kalamaras, J, Hartigan-O’Connor, D, et al. (1998) “Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells” Development 125: 2213–2221 Sussel, I, Kalamaras, J, Hartigan-O’Connor, D, et al. (1998) “Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells” Development 125: 2213–2221
118.
go back to reference Sander, M, Sussel, L, Conners, J, et al. (2000) “Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas” Development 127: 5533–5540 Sander, M, Sussel, L, Conners, J, et al. (2000) “Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas” Development 127: 5533–5540
119.
go back to reference Naya, FJ, Huang, HP, Qiu, Y, et al. (1997) “Diabetes, defective pancreatic morphgenosis, and abnormal enteroendocrine differentiation in BETA2/Neuro D-deficient mice” Gene Dev. 11: 2323–2334 Naya, FJ, Huang, HP, Qiu, Y, et al. (1997) “Diabetes, defective pancreatic morphgenosis, and abnormal enteroendocrine differentiation in BETA2/Neuro D-deficient mice” Gene Dev. 11: 2323–2334
Metadata
Title
Molecular Targeting of Pancreatic Disorders
Authors
Kiichi Tamada, M.D
Xiao-Ping Wang, Ph.D.
F. Charles Brunicardi, M.D.
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 3/2005
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-004-7821-6

Other articles of this Issue 3/2005

World Journal of Surgery 3/2005 Go to the issue

Letter to the Editor

Letter to the Editor